期刊文献+

氨氯地平阿托伐他汀钙片治疗高血压病合并冠心病的疗效观察 被引量:40

Observation on Efficacy of Amlodipine and Atorvastatin Calcium Tablets in Treatment of Hypertension Complicated with Coronary Heart Disease
在线阅读 下载PDF
导出
摘要 目的:探讨氨氯地平阿托伐他汀钙片治疗高血压病合并冠心病的临床疗效。方法:选择2013年7月—2014年7月160例高血压病合并冠心病患者,按照随机数字表法分成观察组和对照组,每组各80例。对照组患者口服阿托伐他汀钙片,观察组患者口服氨氯地平阿托伐他汀钙片。观察2组患者的血压及血脂变化情况。结果:治疗6个月后,2组患者的收缩压、舒张压均较治疗前明显降低,且观察组降低幅度明显优于对照组,差异均有统计学意义(P<0.05);2组患者总胆固醇、三酰甘油、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇均较治疗前明显改善,且观察组改善程度明显优于对照组,差异均有统计学意义(P<0.05);2组患者均未见明显不良反应。结论:氨氯地平阿托伐他汀钙片治疗高血压病合并冠心病,可明显改善患者的血压及血脂,且安全性较高,值得临床推广。 OBJECTIVE: To probe into the clinical efficacy of Amlodipine and Atorvastatin calcium tablets in treatment of hypertension complicated with coronary heart disease. METHODS: 160 patients with hypertension complicated with coronary heart disease admitted from Jul. 2013 to Jul. 2014 were selected to be divided into observation group and control group via the random number table,with 80 cases in each. The control group were treated with oral Atorvastatin calcium tablets,while the observation group received oral Amlodipine and Atorvastatin calcium tablets. The changes of blood pressure and blood fat in two groups were observed. RESULTS: After treatment of 6 months,the systolic blood pressure,diastolic blood pressure of two groups decreased significantly,and the falling range of observation group was better than that of control group,with statistically significant difference( P〈0. 05).Compared with before treatment,total cholesterol,triacylglycerol,low density lipoprotein cholesterin and high density lipoprotein cholesterol had been significantly improved after treatment,and the improvement in observation group was higher than that of control group,with statistically significant difference( P〈0. 05). There were no obvious adverse drug reactions in two groups. CONCLUSIONS: Amlodipine and Atorvastatin calcium tablets in treatment of hypertension complicated with coronary heart disease can significantly improve the blood pressure and blood fat with high safety,which is worthy of clinical application and promotion.
出处 《中国医院用药评价与分析》 2016年第7期921-923,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 高血压 冠心病 氨氯地平阿托伐他汀钙 临床疗效 Hypertension Coronary heart disease Amlodipine and Atorvastatin calcium tablets Clinical efficacy
作者简介 主管药师。研究方向:医院药学。E-mail:2465963218@qq.com
  • 相关文献

参考文献15

二级参考文献151

  • 1宗刚军,周辽军,吴刚勇,陈景开.普伐他汀改善冠心病合并高血压患者脉压的疗效[J].心血管康复医学杂志,2006,15(5):480-482. 被引量:6
  • 2《中国高血压防治指南》修订委员会.中国高血压防治指南2010修订版[M].北京:人们卫生出版社,2010:40.
  • 3Sun Y,Chien KL,Hsu HC,et al.Use of serum homocysteine to predict stroke,coronary heart disease and death in ethnic Chinese[J].Circ J,2009,73(8):1423-1430.
  • 4Jarosz A,Nowicka G.C-reactive protein and homocysteine as risk factors of atherosclerosis[J].Przegl Lek,2008,65(6):268-272.
  • 5Perna AF,Ingrosso D,Lombardi C,et al.Possible mechanisms of homocysteine toxicity[J].Kidney Int Suppl,2003,63(84):137-140.
  • 6Wang G,Dai J,Mao J,et al.Folic acid reverses hyperresponsiveness of LPS-induced chemokine secretion from monocytes in patients with hyperhomocysteinemia[J].Atherosclerosis,2005,179(2):395-402.
  • 7Pizzolo F,Friso S,Olivier O,et al.Homocysteine,traditional risk factors and impaired renal function in coronary artery disease[J].Eur J Clin Invest,2006,36(10):698-704.
  • 8Daly C,Fitzqerald AP,O′Callaqhan P,et al.Homocysteine increases the risk associated with hyperlipidaemia[J].Eur J Cardiovasc Prev Rehabil,2009,16(2):150-155.
  • 9中华人民共和国卫生部.中药新药临床研究指导原则[S].北京:中国医药科技出版社,2002.68-74.
  • 10陈灏珠,主编.心脏病学[M].北京:人民卫生出版社,2003.1001.

共引文献691

同被引文献172

引证文献40

二级引证文献222

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部